CLINICAL TRIALS PROFILE FOR EXCEDRIN (MIGRAINE RELIEF)
✉ Email this page to a colleague
All Clinical Trials for EXCEDRIN (MIGRAINE RELIEF)
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01629329 ↗ | Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine | Terminated | Albert Einstein Healthcare Network | Phase 4 | 2010-11-01 | The objective of this randomized, double blind study is to demonstrate that one dose oral "excedrin migraine" (acetaminophen, aspirin and caffeine) is not inferior when compared to one dose of intravenous prochlorperazine for the treatment of acute migraine headaches in the emergency department. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for EXCEDRIN (MIGRAINE RELIEF)
Condition Name
Clinical Trial Locations for EXCEDRIN (MIGRAINE RELIEF)
Trials by Country
Clinical Trial Progress for EXCEDRIN (MIGRAINE RELIEF)
Clinical Trial Phase
Clinical Trial Sponsors for EXCEDRIN (MIGRAINE RELIEF)
Sponsor Name